Medicare Enrolled

Mackenzie Althouse, APRN

Pediatric Nurse Practitioner · Fort Myers, FL
4310 METRO PKWY STE 205, Fort Myers, FL 33916
2392232751
Registered in NPPES since 2019
NPI: 1679032072 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Althouse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Althouse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Althouse

Mackenzie Althouse is a pediatric nurse practitioner in Fort Myers, FL, with 7 years of NPI registration.

Between the years covered by Open Payments, Althouse received a total of $2,740 from 25 pharmaceutical and/or device companies across 122 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Althouse is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years of NPI registration $2,740 industry payments

Florida License Status

FL DOH · MQA
2
Active licenses
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Registered Nurse 9399649 Clear Expired July 31, 2026 —
Advanced Practice Registered Nurse 11001616 Clear Expired July 31, 2026 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$2,740
Total received (2021-2024)
Avg $685/year across 4 years
Top 5% in FL for pediatric nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
122
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$691
2023
$801
2022
$900
2021
$348

Payments by company (2024)

Tempus AI, Inc
$184
Neurocrine Biosciences, Inc.
$137
Janssen Pharmaceuticals, Inc
$60
Supernus Pharmaceuticals, Inc.
$48
Otsuka America Pharmaceutical, Inc.
$47
Corium, LLC
$42
IRONSHORE PHARMACEUTICALS INC.
$38
Lundbeck LLC
$33
Tris Pharma Inc
$32
Vanda Pharmaceuticals Inc.
$20
Alkermes, Inc.
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Teva Pharmaceuticals USA, Inc.
$15
Top 3 companies account for 55.2% of 2024 payments
All-time payments by company (2021-2024) ›
Corium, LLC
$380
Neurocrine Biosciences, Inc.
$281
Supernus Pharmaceuticals, Inc.
$262
Neuronetics, Inc.
$223
Tempus AI, Inc
$184
Teva Pharmaceuticals USA, Inc.
$160
Alkermes, Inc.
$150
Axsome Therapeutics, Inc.
$146
Janssen Pharmaceuticals, Inc
$133
IDORSIA PHARMACEUTICALS US INC
$115
Sunovion Pharmaceuticals Inc.
$111
Otsuka America Pharmaceutical, Inc.
$96
Ironshore Pharmaceuticals Inc.
$72
ITI, Inc.
$70
Lundbeck LLC
$69
Takeda Pharmaceuticals U.S.A., Inc.
$51
Corium, Inc.
$42
IRONSHORE PHARMACEUTICALS INC.
$38
Tris Pharma Inc
$32
Almatica Pharma LLC
$30
AbbVie Inc.
$23
Vanda Pharmaceuticals Inc.
$20
Indivior Inc.
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Adlon Therapeutics L.P.
$12
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · Azstarys · CAPLYTA · CITALOPRAM · Dyanavel XR · HETLIOZ · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LYBALVI · NEUROSTAR TMS THERAPY SYSTEM · Onyda XR · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · SUBLOCADE · TRINTELLIX · VRAYLAR
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric nurse practitioner in Fort Myers?
Compare pediatric nurse practitioners in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse pediatric nurse practitioners nearby

Geographic Context

Pediatric nurse practitioners in nearby ZIP areas
29
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
LEE MEMORIAL HOSPITAL
2.8 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Althouse is a pediatric nurse practitioner.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Althouse receive payments from pharmaceutical companies?
Yes. Althouse received a total of $2,740 from 25 companies across 122 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Althouse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Nurse Practitioners in Fort Myers
Browse pediatric nurse practitioners in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Nurse Practitioners in FL
Pediatric nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Nurse Practitioners in FL
Which FL pediatric nurse practitioners receive the most from drug and device companies.
By company
Corium, LLC Payments to Doctors
See all physicians who received payments from Corium, LLC.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →